REFERENCES
- Harris RC, Neilson EG. Toward a unified theory of renal progression. Annu Rev Med. 2006;57:365–380.
- Bohle A, Strutz F, Muller GA. On the pathogenesis of chronic renal failure in primary glomerulopathies: A view from the interstitium. Exp Nephrol. 1994;2:205–210.
- Grgic I, Duffield JS, Humphreys BD. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol. 2011. (in press).
- Iwano M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens. 2004;13:279–284.
- Marra F, Aleffi S, Galastri S, Provenzano A. Mononuclear cells in liver fibrosis. Semin Immunopathol. 2009;31:345–358.
- Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214:199–210.
- Shao DD, Suresh R, Vakil V, Gomer RH, Pilling D. Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol. 2008;83:1323–1333.
- Parsonage G, Falciani F, Burman A, . Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns. Thromb Hemost. 2003;90:688–697.
- Buckley CD, Amft N, Bradfield PF, . Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol. 2000;165:3423–3429.
- Zhu C, Anderson AC, Schubart A, . The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol. 2005;6:1245–1252.
- Asakura H, Kashio Y, Nakamura K, . Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9. J Immunol. 2002;169:5912–5918.
- Igawa K, Satoh T, Hirashima M, Yokozeki H. Regulatory mechanisms of galectin-9 and eotaxin-3 synthesis in epidermal keratinocytes: Possible involvement of galectin-9 in dermal eosinophilia of Th1-polarized skin inflammation. Allergy. 2006;61:1385–1391.
- Takahashi Y, Fukusato T, Kobayashi Y, . High expression of eosinophil chemoattractant ecalectin/galectin-9 in drug-induced liver injury. Liver Int. 2006;26:106–115.
- Grimwood L, Masterson R. Propagation and culture of renal fibroblasts. Methods Mol Biol. 2009;466:25–37.
- Caraher EM, Parenteau M, Gruber H, Scott FW. Flow cytometric analysis of intracellular IFN-gamma, IL-4 and IL-10 in CD3(+)4(+) T-cells from rat spleen. J Immunol Methods. 2000;244:29–40.
- Ku BM, Ryu HW, Lee YK, . 4′-Acetoamido-4-hydroxychalcone, a chalcone derivative, inhibits glioma growth and invasion through regulation of the tropomyosin 1 gene. Biochem Biophys Res Commun. 2010;402:525–530.
- Serini G, Gabbiani G. Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res. 1999;250:273–283.
- Pilling D, Akbar AN, Girdlestone J, . Interferon-beta mediates stromal cell rescue of T cells from apoptosis. Eur J Immunol. 1999;29:1041–1050.
- Chen JF, Gao J, Zhang D, Wang ZH, Zhu JY. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(–) naive T cells display more potent regulatory ability in vitro. Chin Med J (Engl). 2010;123:942–948.
- Oldroyd SD, Thomas GL, Gabbiani G, El Nahas AM. Interferon-gamma inhibits experimental renal fibrosis. Kidney Int. 1999;56:2116–2127.
- Harrington LE, Hatton RD, Mangan PR, . Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123–1132.
- Park H, Li Z, Yang XO, . A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133–1141.
- McGaha TL, Bona CA. Role of profibrogenic cytokines secreted by T cells in fibrotic processes in scleroderma. Autoimmun Rev. 2002;1:174–181.
- Guicciardi ME, Gores GJ. Apoptosis as a mechanism for liver disease progression. Semin Liver Dis. 2010;30:402–410.
- Imaizumi T, Kumagai M, Sasaki N, . Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells. J Leukoc Biol. 2002;72:486–491.